Date issued	Product	Safety information
02/04/2007	Mabthera (rituximab)	Reports of progressive multifocal leukoencephalopathy in unapproved indications of systemic lupus erythematosus and vasculitis
11/04/2007	Pioglitazone-containing products (Actos, Glustin, Competact, Tandemact)	Risk of fractures in women on long-term treatment
12/04/2007	Cabaser (cabergoline)	Pathological gambling and increased libido are potential class effects of dopamine agonists Risk of fibrotic cardiac valvuopathy: important information about second-line indication, contraindications, and new monitoring requirements
16/04/2007	Desmopressin	Removal of primary nocturnal enuresis indication
17/04/2007	Ketek (telithromycin)	Important information about restricted indications, contraindications, and safety measures
27/04/2007	Ventolin (salbutamol)	New prescribing advice for obstetric use in the management of preterm labour and for use in respiratory disease

Page last modified: 07 February 2008

Find out about who we are and what we do. Also find out about working for us...

Find out how we regulate medicines (including herbal medicines), devices, tissue engineering, nanotechnology and blood...

Safety alerts, warnings, information and advice. Also how you can report a safety problem...

Information on our advisory committees including their meeting minutes and membership...

Details of our conferences, seminars and learning resources on topics related to our work...

Sign-up for email notifications; report safety problems and links to other online services...

Details of our vast array of publications, many available to view online...

Breaking news and a full archive of our press releases. Also our press contacts and image library...

Give us your views on our consultations and our website. Also how you can make a complaint...

Safety information on medicines for healthcare professionals sent April 2007

Help viewing PDFs: